▲ Samsung Biologics
Labor and management at Samsung Biologics, who have been locked in conflict for over half a year over wage increases and personnel system improvements, are expected to delay the resumption of negotiations.
Samsung Biologics announced today (Nov. 2) that it has proposed to the labor union to postpone the labor-management negotiations, which were scheduled to begin on the 3rd, by two weeks.
Regarding the postponement of negotiations, Samsung Biologics stated, "On October 30, the union unilaterally denied the status of management's negotiating commissioners by demanding the complete exclusion and replacement of the company's chief negotiator."
The company added that behind preparations for dialogue, the union is preparing for strikes and putting pressure on the company by utilizing upper-level labor organizations, stating, "We are concerned that proceeding with negotiations in the current environment would further undermine mutual respect and trust."
Samsung Biologics stated, "Even during the two-week grace period to restore trust, if the union halts unilateral pressure tactics and requests dialogue based on mutual respect and trust, we plan to resume talks at any time."
Previously, the Samsung Biologics Sangsaeng Labor Union defined these negotiations as "all-or-nothing talks" and stated that if they break down, it will launch sequential strikes.
The union had planned to hold a three-week general strike late last month, but decided to postpone the strike and resume negotiations after the court significantly expanded the scope of injunctions prohibiting labor disputes.
After conciliation with management broke down on March 23, the union staged a partial strike in late April followed by a full strike from May 1 to 5, and has since continued compliance struggles by refusing overtime and holiday work.
(Photo provided by Samsung Biologics, Yonhap News)
※ Please note: This article was translated by AI and may contain errors.
Video News
Video News
Video News
Video News
Video News